Preeclampsia, a condition that affects 10 million women worldwide, disproportionately impacts mothers and infants in developing countries and is a major cause of maternal death. 

Mirvie receives a $4.6M grant from the Gates Foundation to study preeclampsia in Sub-Saharan Africa.

Helpful App raises $7.5M in seed funding to streamline caregiver support.

Peterson Center on Healthcare launches a $50M initiative to evaluate digital health innovations.

BPEA EQT is to acquire a majority stake in Indira IVF, India’s largest chain of fertility clinics.

The FDA approves the first oral treatment for postpartum depression.

New research assesses mobile apps providing abortion information.

This week’s newsletter is powered by Lightmatter:

Lightmatter is a US-based agency of engineers, designers, and product experts that build software exclusively for companies in health.

Drawing from years of experience in the space, Lightmatter’s team will help you navigate the technical and creative challenges you’ll inevitably encounter while developing a digital health product. Their deep expertise in healthcare is the reason leaders at FemTech companies like Cofertility and Upliv trust them to build, launch, and scale their software applications.

Whether in a project-based or staff augmentation model, Lightmatter can help. Send an email to today to learn more!

In the Know

Loneliness is killing us. Yet Community-Focused Femtech Startups Can’t Seem to Make It Work (Femtech Insider)

Flo Health survey reveals knowledge gaps and lack of access to credible health information in post-Roe America. (Femtech Insider)

Want Outsized Returns? Invest in Menopause Products.  (Entrepreneur)

A new study put period products through the wringer. Discs came out a winner (STAT News)

From heart disease to IUDs: How doctors dismiss women’s pain. (Washington Post)

Virtual Women’s Health: State of Play (Axios)

Show CommentsClose Comments

Leave a comment